Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morhulin
- Development stage
- Unknown
- Lead developer
- Thornton & Ross
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Morhulin is an over-the-counter topical ointment used for the treatment of minor skin conditions such as nappy rash, eczema, minor wounds, grazes, pressure sores, and varicose ulcers. The formulation contains two primary active ingredients: zinc oxide (38% w/w) and cod liver oil (11.4% w/w). Zinc oxide functions as a protective barrier and assists in the debridement of dead tissue from wounds, while cod liver oil, containing vitamin A, promotes the healing process and skin regeneration. Originally developed by Thornton & Ross, the product is currently owned by Actavis Group PTC ehf and is supplied as a smooth, white ointment for topical application.
- Brand names
- Morhulin
Beyond the preview
Go deeper on Morhulin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Morhulin.